About EurFMT

Updated 15Jan2026

The European Faecal Microbiota Transplantation Network (EurFMT Network) is an international collaboration of academic FMT centers, aiming to promote the implementation and use of faecal microbiota transplantation (FMT) in clinical practice and research. As a dynamic network, EurFMT aims to bridge the gap between faecal microbiota transplantation experts across Europe, fostering innovation and excellence in this promising field of medicine.

Objectives

A primary objective of EurFMT is to improve communication within the FMT community. By facilitating knowledge exchange and collaboration, the network ensures that members stay up-to-date on the latest developments in FMT research and clinical applications. This collaborative approach allows for rapid dissemination of new findings, ultimately accelerating the progress of FMT as a therapeutic modality.

EurFMT fosters communication and is committed to implementing mutual quality control options. By establishing standardized procedures and guidelines, the network ensures that FMT practices across its member centers maintain the highest quality and safety standards. This harmonized approach not only benefits patients but also strengthens the credibility and integrity of FMT research.

EurFMT overall serves as a common platform for academics in the field of faecal microbiota transplantation. By fostering collaboration, communication, and quality control, the network actively contributes to the progress of FMT in both clinical practice and research. Through the combined efforts of its members, EurFMT strives to impact the advancement of FMT implementation and utilization across borders.

EurFMT members

EurFMT is open to any academic in Europe who is already involved or interested in implementing FMT as a medical therapy, based on the tissue standards applied to substances of human origin (SoHO). Application for membership should be sent via e-mail to coordinator Lisa Weipert at weipert@med.uni-frankfurt.de. The email should contain a brief motivation for your inclusion in the network and a 2-pages curriculum vitae. The application is handled by the steering committee.

General assemblies

The EurFMT Network organizes two general assemblies, or meetings, per year, one virtual and one with physical attendance. The assemblies are typically planned in relation to a relevant International congress. The agenda of each general assembly is be based on the input of the EurFMT members.

Steering committee

The EurFMT steering committee comprises 12 elected members from 8 countries. The members are elected by the EurFMT network.
The steering committee is elected by the network and coordinates general and ad hoc activities. See the steering committee here.

EurFMT Steering group

Alexander Link

Professor, MD, PhD

Clinic for Gastroenterology, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Bayreuth, Germany

Benjamin Mullish

MB BChir, PhD, MRCP

Division of Digestive Diseases, Department of Metabolism, Digestion and Reproduction, Faculty of Medicine, Imperial College London, London, United Kingdom.

Christian Lodberg Hvas

Professor, MD, PhD

Department of Hepatology and Gastroenterology, Aarhus University Hospital, Aarhus, Denmark.

Gianluca Ianiro

Adjunct Professor of Gastroenterology, MD, PhD

Department of Gastroenterology, Fondazione Policlinico Universitario “A. Gemelli” IRCCS, Rome, Italy;
Università Cattolica del Sacro Cuore, Rome, Italy.

Harry Sokol

Professor, MD, PhD

Department of Gastroenterology, Saint-Antoine Hospital, Assistance Publique–Hôpitaux de Paris (AP-HP), Paris, France.

Josbert J. Keller

MD, PhD

Department of Gastroenterology, Haaglanden Medical Center, The Hague, The Netherlands.

Juozas Kupčinskas

Professor, MD, PhD

Department of Gastroenterology and Institute for Digestive Research
Lithuanian University of Health Sciences, Kaunas, Lithuania.

Lindsey A. Edwards

BSc, MSc, DLSHTM, PhD

Institute of Liver Studies, School of Immunology and Microbial Sciences, Faculty of Life Sciences and Medicine, King’s College London, London, United Kingdom.

Elizabeth M. (Liz) Terveer

MD, PhD

Department of Medical Microbiology, Leiden University Medical Center, Leiden, The Netherlands.

Maria J. G. T. Vehreschild

Professor, Dr.med.

Department of Internal Medicine (Infectious Diseases), University Hospital Frankfurt, Goethe University Frankfurt, Frankfurt am Main, Germany.

Reetta Satokari

Adjunct Professor, PhD

Human Microbiome Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland.

Simon Mark Dahl Baunwall

MD, PhD

Department of Hepatology and Gastroenteorlogy, Aarhus University Hospital, Denmark.